Innate immune training is defined as a property of innate immune cells to react stronger to a secondary contact with pathogens. Induction of innate immune training has been reported for a variety of pathogens and selected pattern recognition receptor-ligands, such as β-glucans (βG). We examined whether Saccharomyces cerevisiae cell wall component βG induces training in bovine monocytes in vitro based on a heightened TNF secretion after stimulation by trained monocyte-derived macrophages with Escherichia coli LPS. Sorted CD14-expressing monocytes (classical and intermediate monocytes), as well as single populations of sorted classical, intermediate and non-classical monocytes could not be trained by βG, whereas macrophages derived from plastic-adherent mononuclear cell preparations displayed features of a trained function. The hypothesis, that non-classical monocytes need to be present in a mixed monocyte population in order to be trained by βG could be verified by a successful training of positively sorted whole monocyte populations (CD14CD16/M) containing all three monocyte subpopulations. The trainability depended on conditions favoring M1 polarization of macrophages. Altogether, innate immune training of bovine monocytes seems to depend on the presence of non-classical monocytes. This adds new information to the role of this monocyte subpopulation in the bovine immune system.
Innate immune training is defined as a property of innate immune cells to react stronger to a secondary contact with pathogens. Induction of innate immune training has been reported for a variety of pathogens and selected pattern recognition receptor-ligands, such as β-glucans (βG). We examined whether Saccharomyces cerevisiae cell wall component βG induces training in bovine monocytes in vitro based on a heightened TNF secretion after stimulation by trained monocyte-derived macrophages with Escherichia coli LPS. Sorted CD14-expressing monocytes (classical and intermediate monocytes), as well as single populations of sorted classical, intermediate and non-classical monocytes could not be trained by βG, whereas macrophages derived from plastic-adherent mononuclear cell preparations displayed features of a trained function. The hypothesis, that non-classical monocytes need to be present in a mixed monocyte population in order to be trained by βG could be verified by a successful training of positively sorted whole monocyte populations (CD14CD16/M) containing all three monocyte subpopulations. The trainability depended on conditions favoring M1 polarization of macrophages. Altogether, innate immune training of bovine monocytes seems to depend on the presence of non-classical monocytes. This adds new information to the role of this monocyte subpopulation in the bovine immune system.
The term innate immune memory describes the phenomenon where contact of innate immune
cells with a pathogen or pathogen-associated molecular pattern (PAMP) leads to an
altered reaction to subsequent pathogen or PAMP contact. Innate immune memory can be
acquired in one of two ways, either through a lower secondary reaction, called
tolerance, or through a stronger secondary reaction, called innate immune training
or trained immunity.
Innate immune training was described as a feature of the Bacille
Calmette-Guérin (BCG) vaccine, directed against human tuberculosis, as early as 2012.
Importantly, innate immune training also involves a heightened secondary
response to different pathogens or PAMPs. In case of the BCG vaccination, human
peripheral blood mononuclear cells (PBMCs) display a stronger pro-inflammatory
response against Staphylococcus aureus and Candida
albicans. A similar training effect was shown with Candida
albicans, leading to a stronger reaction against Mycobacterium
tuberculosis, mediated by Candida albicans cell wall
β–Glucan (βG). βG induces training in human CD14+ monocytes, which is at least
partially dependent on complement receptor 3 and Dectin-1.
In the following years, βG was used as a positive control for training
experiments in human plastic-adherent monocytes and the kinetics were explored,
too.[4,5] Treatment with
βG leads to epigenetic changes, which form the basis for the altered reaction
pattern towards pathogens later on. In addition to a different inflammatory
reaction, epigenetic signatures of metabolic pathways are also changed by βG.In bovines, little is known about innate immune memory. Although old reports about
innate immune tolerance exist,[7,8] innate immune training in
bovines has only been evaluated with BCG. BCG induces innate immune training
in vivo and in vitro, characterized by a
higher IL-1β, TNF and IL-6 secretion by mononuclear cells from BCG-vaccinated
animals. A different reaction was observed towards LPS and Pam3CSK4, agonists of
Toll-like receptor (TLR)4 and TLR2/TLR1, respectively and changes in TNF secretion
could be followed up for 12 weeks after vaccination.
In addition, innate immune training in bovine was demonstrated by a higher
phagocytic activity of neutrophilic granulocytes from vaccinated animals. Of note,
this was only shown for a second contact with the same pathogen.
While these first results in bovine look promising, their relevance for
practical application is questionable. As BCG vaccination of cattle interfere with
tuberculin skin tests, they cannot be established in countries using this screening
method for tuberculosis.
This prompted us to investigate whether βG can serve as an alternative for
the induction of bovine innate immune training. Just recently, Pedro et al. showed
that particulate βG, as used herein, leads to a proinflammatory response by bovine
monocytes and they speculated, that trained immunity could be induced by βG in bovines.
Furthermore, we focused on the involvement of the different monocyte
subpopulations in innate immune training, an issue not addressed so far in the
human, bovine or murine system.[13,14] As in humans, bovine
monocytes are divided into three subsets characterized by their expression of CD14
and CD16, with classical monocytes expressing mainly CD14, intermediate monocytes
expressing both surface markers and non-classical monocytes expressing mainly CD16.
Methods
Isolation of bovine mononuclear cells
Heparinized venous blood from the left jugular vein was taken from 5–6 healthy,
non-lactating, non-pregnant Holstein-Frisian cows, aged 8.6 ± 3.0 years, housed
at the Clinic for Cattle, University of Veterinary Medicine, Foundation,
Hanover, Germany. Blood was drawn into heparinized vacutainer (Becton Dickinson,
Heidelberg, Germany) and PBMCs were isolated by density centrifugation over
lymphocytes separation media® (Capricorn Scientific GmbH). After centrifugation
(1000 x g, 30 Min, 4°C and 500 x g, 10 min,
4°C), contaminating erythrocytes were lysed by adding 20 ml distilled water for
10 s. After adding the same volume of double-concentrated PBS, cells were washed
twice (250 x g and 120 x g, 10 Min, 4°C).
Generation of plastic-adherent monocytes (Pa/M)
2 × 106 PBMCs per well were cultured in 24-well-plates for 20 h (37°C,
5% CO2 in air). Non-adherent cells were removed by washing the wells
with 1 ml warm PBS.
Isolation of CD14+ monocytes (classical and intermediate monocytes;
CD14/M)
PBMCs were filtered through pre-separation filters (MACS Miltenyi Biotec GmbH,
Bergisch Gladbach, Germany) to remove cell aggregates. Afterwards, cells were
incubated with 10 µl of paramagnetic anti-CD14 beads (MACS Miltenyi Biotec GmbH,
Bergisch Gladbach, Germany) per 1 × 107 vital PBMCs for 30 min at
4°C. Unbound beads were removed by washing the cells once with 10 ml MACS buffer
(PBS, 5 g/l bovine serum albumin (BSA), 1.344 g/l EDTA) (400 x
g, 10 min, 4°C). Cells were resuspended in 3 ml MACS
buffer, added to a LS separation column and mounted into a Quadro MACS station.
After the elimination of flow-through cells, CD14-expressing cells were
harvested by removing the column from the Quadro MACS station and rinsing it
with 5 ml MACS buffer.
Isolation of classical (cM), intermediate (intM) and non-classical (ncM)
monocytes
Classical (CD14+CD16-), intermediate (CD14+CD16+) and non-classical monocytes
(CD14-CD16++) were isolated by a two-step MACS procedure, essentially described
in Hussen et al..
Isolated PBMCs were labeled with FITC-conjugated anti-CD16 antibodies by
adding 10 µl of antibody solution to 1 × 107 PBMCs for 30 min (4°C).
Unbound antibodies were removed by washing the cells twice with 10 ml MACS
buffer. Subsequently, cells were labeled with 10 µl paramagnetic anti-FITC beads
(30 min, 4°C). Unbound beads were removed by washing with 10 ml MACS buffer (400
* g, 10 Min, 4°C). Cells were subsequently added to a LS
separation column in a Quadro-MACS station. CD16-negative cells were harvested
from the flow-through and CD16-positive were harvested by removing the column
from the Quadro-MACS station and rinsing it with 5 ml MACS buffer. Positively
selected CD16+ cells were incubated with 100 µl of release reagent (MACS
Miltenyi Biotec GmbH, Bergisch Gladbach) to remove the bound paramagnetic
particles and placed onto a new LS separation column. CD16+ cells with no
adherent paramagnetic particles were thus collected in the flow-through. Those
CD16+ cells and the CD16- cells were labeled with 10 µl of anti-CD14-beads per
1 × 107 cells (30 Min, 4°C). 50 µl stop reagent was added
simultaneously to the CD16+ cells to inhibit the release reagent. Afterwards,
cells were washed once to remove unbound beads (400 * g,
10 Min, 4°C). Cells were placed on a LS separation column in a Quadro-MACS
station and flow-through (CD14-) as well as magnetically labeled cells inside
the column (CD14+) collected. In detail, the flow-through of the CD16+ cells
contained ncM (CD14-CD16++), the magnetically labeled CD16+ cells were intM
(CD14+CD16+). Magnetically labeled CD16- cells were cM (CD14+CD16-), while the
flow-through of the CD16- cells contained no monocytes (CD14-CD16-). All
obtained cell suspensions were characterized by flow cytometry for their
expression of CD14 and CD16 (Figure 2). Classical monocytes (CD14+CD16-; cM), intermediate
monocytes (CD14+CD16+; intM) and non-classical monocytes (CD14-CD16+, ncM) were
used for training experiments.
Figure 2.
Flow cytometry of isolated PBMC, monocytes and macrophages. Peripheral
blood mononuclear cells and monocytes were isolated and stained with
antibodies against CD14 and CD16 as well as with propidium iodide.
Gating of stained cells is shown in a. Monocyte subset content in the
differently isolated PBMC and monocytes is shown in b. Obtained cells
after culturing of PBMC and CD14/M for 5 days is shown in c. PBMC:
Peripheral blood mononuclear cells, FSC: Forward scatter, SSC: Sideward
scatter, FSC A: Forward scatter area, FSC H: Forward scatter area, PI:
Propidium iodide, CD: Cluster of differentiation, PA/M: Plastic adherent
monocytes, CD14/M: CD14 expressing monocytes, CD14CD16/M: CD14- or CD16
expressing monocytes, cM: Classical monocytes, intM: Intermediate
monocytes, ncM: Non classical monocytes, PA/Mph: Macrophages derived
from PA/M, CD14/Mph: Macrophages derived from CD14/M.
Flow cytometry of isolated PBMC, monocytes and macrophages. Peripheral
blood mononuclear cells and monocytes were isolated and stained with
antibodies against CD14 and CD16 as well as with propidium iodide.
Gating of stained cells is shown in a. Monocyte subset content in the
differently isolated PBMC and monocytes is shown in b. Obtained cells
after culturing of PBMC and CD14/M for 5 days is shown in c. PBMC:
Peripheral blood mononuclear cells, FSC: Forward scatter, SSC: Sideward
scatter, FSC A: Forward scatter area, FSC H: Forward scatter area, PI:
Propidium iodide, CD: Cluster of differentiation, PA/M: Plastic adherent
monocytes, CD14/M: CD14 expressing monocytes, CD14CD16/M: CD14- or CD16
expressing monocytes, cM: Classical monocytes, intM: Intermediate
monocytes, ncM: Non classical monocytes, PA/Mph: Macrophages derived
from PA/M, CD14/Mph: Macrophages derived from CD14/M.
Isolation of whole monocyte populations (CD14CD16/M)
Monocytes composed of all subpopulations (cM, intM and ncM) were positively
separated by a single step MACS procedure. Isolated bovine PBMC were
simultaneously incubated with anti-CD14 beads and anti-CD16 beads
(10 µl/1 × 107 vital PBMC, 30 min, 4°C). Cells were washed with
10 ml MACS buffer (400 * g, 10 Min, 4°C) and resuspended in
3 ml MACS buffer. Sorting was done as described above. This resulted in monocyte
purity of 87–94% of all measured cells and those monocytes had a viability of
99.6 to 99.9%.
Training and polarization of monocytes
For training experiments, different numbers of cells were seeded in 1 ml in
24-well plates. For PA/M, 2 × 106 PBMCs were seeded. PBMC
preparations contained up to 20% monocytes. Therefore, CD14/M and CD14CD16/M
were seeded in a final cell number of 4 × 105 cells. For cM, intM and
ncM, 2 × 105 cells/well were seeded. Cells were cultured in modified
RPMI medium (cRPMI), supplemented with 10% fetal calf serum, 1%
penicillin-streptomycin, HEPES, non-essential amino acids, sodium pyruvate and
2-mercaptoethanol as stated in Guerra-Maupome et al.
On day 1 of culture, cells were washed once with 1 ml of PBS. After that,
the cells were supplied with 1 ml fresh medium (control) or medium containing
WGP Dispersible (InvivoGen, tlrl-wgp, wgp: whole glucan particles of
Saccharomyces cerevisiae lacking TLR-stimulating activity;
referred to as βG) at indicated concentrations. On day 2 of culture, cells were
washed once with warm medium and supplied with fresh medium. On day 4 of
culture, medium was removed and replaced by 1 ml fresh medium (control) or with
10 ng LPS from E. coli O111:B4 (Merck KGaA). To parallel set
ups, recombinant bovine GM-CSF and recombinant bovine IFN-γ (Biomol, 35 µl stock
solution, each 20 ng/ml final) was added daily to promote differentiation of
monocytes into M1 macrophages (M1 Mph). Cultures supplemented daily with the
same amount of PBS are referred to as M0 Mph (Figure 1).
Figure 1.
Protocol for βG-training. Monocytes were isolated using different
techniques, resulting in different seeded cell compositions. Those cells
were conditioned with βG on day 1, supernatant were removed on day 2 and
fresh medium was added. On day 4, cells were stimulated with LPS. Cells
were termed as M0 Mph and analyzed along with the supernatant on day 5.
In another attempt, the protocol was modified by daily supplementation
of GM CSF and IFN-γ. In this approach, cells were termed M1 Mph on day
5. PA/M: Plastic adherent monocytes, CD14/M: CD14 expressing monocytes,
CD14CD16/M: CD14- or CD16 expressing monocytes, βG: β glucan, LPS:
Lipopolysaccharide, Mph: Macrophages, E. coli: Escherichia coli, GM CSF:
Granulocyte macrophage colony stimulating factor, IFN-γ: Interferon
γ.
Protocol for βG-training. Monocytes were isolated using different
techniques, resulting in different seeded cell compositions. Those cells
were conditioned with βG on day 1, supernatant were removed on day 2 and
fresh medium was added. On day 4, cells were stimulated with LPS. Cells
were termed as M0 Mph and analyzed along with the supernatant on day 5.
In another attempt, the protocol was modified by daily supplementation
of GM CSF and IFN-γ. In this approach, cells were termed M1 Mph on day
5. PA/M: Plastic adherent monocytes, CD14/M: CD14 expressing monocytes,
CD14CD16/M: CD14- or CD16 expressing monocytes, βG: β glucan, LPS:
Lipopolysaccharide, Mph: Macrophages, E. coli: Escherichia coli, GM CSF:
Granulocyte macrophage colony stimulating factor, IFN-γ: Interferon
γ.
Antibodies and flow cytometry
PBMC and sorted monocyte populations were labeled with primary antibodies to
identify monocyte subpopulations. Cells were washed once in 200 µl membrane
immunofluorescence buffer (MIF buffer, PBS, 0.5% PBS, 0.01% NaN3).
After centrifugation (350 x g, 4°C, 4 Min), the supernatant was
discarded and cells were resuspended for 30 Min (4°C) in 30 µl MIF buffer
containing a mixture of two murine bovine cross-reactive monoclonal antibodies
(anti-CD14, RRID AB_566517, IgG2a, clone TÜK4, 1:45 final; anti-CD16, RRID
AB_10961759, IgG2a, clone KD1, 1:45 final, both Bio-Rad). Cells were washed
twice with 200 µl MIF buffer and resuspended in 100 µl MIF buffer for analysis
by flow cytometry.Differentiated and adherent macrophages (day 5 of culture) were detached by
adding 200 µl Accutase/well (20 Min, 37°C). Detachment was stopped by addition
of culture medium. Cells were washed once in 200 µl MIF buffer (351 x
g, 4 Min, 4°C). Suspended cells were incubated (30 min, at
4°C) with an ovine-specific (bovine cross-reactive) murine monoclonal antibody
specific for MHC class-II (anti-MHC-II-FITC, RRID AB_323966, IgG2a, clone 37.68,
final 1:45 in MIF buffer). Cells were washed twice with 200 µl MIF buffer (351 x
g, 4 Min, 4°C) and resuspended in 100 µl of MIF buffer for
analysis by flow cytometry.Propidium iodide (2 µg/ml final) was added to labeled cells to exclude necrotic
and late apoptotic cells. Cells were measured by flow cytometry (Accuri flow
cytometer, BD Biosciences) and data were analyzed using the BD Accuri™ C6
software (BD Biosciences).
TNF quantification
TNF amounts were measured using TNF Duoset® ELISA (R&D Systems), according to
the manufacturer’s instructions. In short, 96-well Nunc Maxisorp™ plates
(ThermoFisher Scientific, Waltham, MA) were coated for 18 h with a monoclonal
antibody specific for bovine TNF. Plates were washed three times with a wash
buffer (PBS, 0.05% Tween® 20) and blocked with reagent diluent (PBS, 5% Tween®
20) for 60 min. After washing, 100 µl of cell culture supernatants, culture
medium (negative control) and a dilution series of the TNF standard were added.
Plates were incubated for 120 min at room temperature with permanent lateral
shaking. After washing, 100 µl of the secondary antibody diluted in reagent
diluent with heat-inactivated normal goat serum were added and plates were
incubated for 120 min with lateral shaking at room temperature. After washing,
100 µl Streptavidin-horseradish peroxidase (1:400 diluted in reagent diluent)
was added. The plates were incubated for 20 min in the dark at room temperature
and washed again. 1 ml 3,3′, 5,5′-Tetramethyl[1,1′-diphenyl]-4,4′-diamin
(1 mg/ml DMSO) and 40 µl H2O2 (3% v/v) were mixed with
10 ml of substrate buffer (Aqua dest., 6.398 g/l citric acid, 11.866 g/l
disodium hydrogen phosphate) and 100 µl were added per well. The enzymatic
reaction was stopped by the addition of 50 µl 1 N H2SO4.
The optical density was determined by a microplate reader set to 450 nm,
wavelength correction was set to 540 nm. The standard curve was created by
four-parameter logistic regression using GraphPad Prism.
Statistical analysis
Statistical analysis was performed using SAS Enterprise Guide, Version 7.12 (SAS
Institute Inc.). In case of normal distribution, paired Students t-test and
ANOVA was applied. In case of non-normal data distribution, Wilcoxon signed-rank
test and Friedman test were used to test for significance of differences. The
relation between memory effect and cell subpopulations was checked for
significance using the Spearman signed rank test. A Memory Effect
(Me) was calculated as stated in equation (1).
Calculation of memory effect
TNF concentrations in supernatants of βG-conditioned (cond) and LPS-stimulated
(stim) monocyte-derived macrophages were divided by TNF concentrations in
supernatants of non-conditioned and LPS-stimulated monocyte-derived
macrophages.
Results
Monocytes were separated in different ways to be used for training experiments.
Isolated PBMCs contained 11.5–22.0% monocytes, composed of 48.3–71.3% cM, 16.8–44.1%
intM, and 7.6–13.6% ncM as well as lymphocytes (Figure 2b, PBMC for PA/M). Those PBMCs were
cultured overnight and washed the following morning to select adherent cells. This
procedure led to a fraction of contaminating lymphocytes in the macrophages at day 5
between 3.9% and 12.8% (Figure 2c). Monocytes isolated as CD14+PBMCs had a purity of 52.4–91.1%
(% monocytes of all cells, data not shown) and contained no lymphoid cells on day 5
(Figure 2c). Those
monocytes are referred to as CD14/M and were composed of cM and intM, while ncM were
absent (Figure 2b CD14/M).
Isolation of single monocyte subsets resulted in populations of cM (median 74.1% cM
of vital cells; Figure 2b
cM), whereas intM and ncM (Figure 2b intM/ncM) had a lower purity (56.9% intM of vital cells; 51.4%
ncM of vital cells). The established method to isolate mixed populations composed of
cM, intM, and ncM resulted in purities of 87–94%. Those cells are referred to as
CD14CD16/M and were composed of 50.3–76.8% cM (coefficient of variation 14.93%),
11.6–35.3% intM (coefficient of variation 45.89%), and 6.3–17.6% ncM (coefficient of
variation 31.88%). CD16+CD335+natural killer cells were absent in this monocyte
preparation (Figure 2b
CD14CD16/M, Figure S2).
Numbers of vital macrophages differentiated from PA/M, CD14/M, or CD14CD16/M under
M1-polarizing conditions were higher than those of Mph differentiating under M0
conditions (Figure 3). The
number of viable M0 or M1 Mph were not altered significantly by βG-conditioning
(Figure 3). If Mph were
stimulated with LPS, βG-conditioning resulted in a significantly higher number of
harvested M0 and M1 Mph derived from CD14CD16/M (Figure 3e and f).
Figure 3.
Viable macrophages. Monocytes were selected as PA/M (a, b), CD14/M (c, d) or
CD14CD16/M (e, f) and submitted to the protocol seen in Figure 1, shortly cells were
conditioned with 10 µg of βG and stimulated with 10 ng of LPS, with a 48
h-break in between. Daily supplementation with GM-CSF and IFN-γ resulted in
M1 Mph, displayed in b, d and f. Viable macrophages were measured by flow
cytometry, morphologically gating on macrophages and excluding
propidium-iodide-positive cells. Shown are the number of macrophages in one
metered µl. Statistical differences are indicated
(*P < 0.05). PA/Mph: Plastic adherent macrophages
derived from PA/M, CD14/Mph: Macrophages derived from CD14/M, CD14CD16/Mph:
Macrophages derived from CD14CD16/M, βG: β-glucan, LPS: Lipopolysaccharide,
Mph: Macrophages, GM-CSF: Granulocyte macrophage colony stimulating factor,
IFN-γ: Interferon γ.
Viable macrophages. Monocytes were selected as PA/M (a, b), CD14/M (c, d) or
CD14CD16/M (e, f) and submitted to the protocol seen in Figure 1, shortly cells were
conditioned with 10 µg of βG and stimulated with 10 ng of LPS, with a 48
h-break in between. Daily supplementation with GM-CSF and IFN-γ resulted in
M1 Mph, displayed in b, d and f. Viable macrophages were measured by flow
cytometry, morphologically gating on macrophages and excluding
propidium-iodide-positive cells. Shown are the number of macrophages in one
metered µl. Statistical differences are indicated
(*P < 0.05). PA/Mph: Plastic adherent macrophages
derived from PA/M, CD14/Mph: Macrophages derived from CD14/M, CD14CD16/Mph:
Macrophages derived from CD14CD16/M, βG: β-glucan, LPS: Lipopolysaccharide,
Mph: Macrophages, GM-CSF: Granulocyte macrophage colony stimulating factor,
IFN-γ: Interferon γ.
Influence of βG-conditioning on M1-marker expression depends on the monocyte
preparation
M1 Mph significantly expressed higher levels of MHC class II molecules. Based on mean
fluorescence intensity levels, the fold changes (M1 versus M0) were 1.77 (PA/Mph),
2.68 (CD14/Mph), and 2.23 (CD14CD16/Mph) (Figure 4). LPS stimulation significantly
lowered the MHC class II expression of M0 PA/Mph but not M0 CD14/MPh and M0
CD14CD16/MPh (Figure 4a, c
and e). In addition, only M0 PA/Mph displayed a significantly reduced MHC II
expression after conditioning with βG (Figure 4a). LPS stimulation of all
macrophage populations differentiating under M1-polarizing conditions resulted in a
significantly reduced MHC-class II expression density (Figure 4b, d and f). βG-conditioning reduced
MHC class II expression only in M1 PA/Mph and M1 CD14/Mph (Figure 4b and d). In M1 CD14/Mph the βG
conditioning significantly pronounced the LPS stimulation-induced drop of MHC class
II expression.
Figure 4.
Phenotype of bovine macrophages. Monocytes were selected as PA/M (a, b),
CD14/M (c, d) or CD14CD16/M (e, f) from six different animals and submitted
to the protocol seen in Figure 1, shortly cells were conditioned with 10 µg of βG and
then stimulated with 10 ng of LPS, with a 48 h-break in between. Daily
supplementation with GM-CSF and IFN-γ occurred in b, d and f. Expression of
MHC II was measured by immunofluorescence and flow cytometric detection
after exclusion of dead cells. Statistical significant differences are
indicated (*P < 0.05). MHC-II: Major histocompatibility
complex II, PA/Mph: Plastic adherent macrophages derived from PA/M,
CD14/Mph: Macrophages derived from CD14/M, CD14CD16/Mph: Macrophages derived
from CD14CD16/M, βG: β glucan, LPS: Lipopolysaccharide, GM CSF: Granulocyte
macrophage colony stimulating factor, IFN-γ: Interferon γ.
Phenotype of bovine macrophages. Monocytes were selected as PA/M (a, b),
CD14/M (c, d) or CD14CD16/M (e, f) from six different animals and submitted
to the protocol seen in Figure 1, shortly cells were conditioned with 10 µg of βG and
then stimulated with 10 ng of LPS, with a 48 h-break in between. Daily
supplementation with GM-CSF and IFN-γ occurred in b, d and f. Expression of
MHC II was measured by immunofluorescence and flow cytometric detection
after exclusion of dead cells. Statistical significant differences are
indicated (*P < 0.05). MHC-II: Major histocompatibility
complex II, PA/Mph: Plastic adherent macrophages derived from PA/M,
CD14/Mph: Macrophages derived from CD14/M, CD14CD16/Mph: Macrophages derived
from CD14CD16/M, βG: β glucan, LPS: Lipopolysaccharide, GM CSF: Granulocyte
macrophage colony stimulating factor, IFN-γ: Interferon γ.
Monocyte preparations differ in their response to βG
PA/M cultured with or without M1-polarizing cytokines secreted TNF in response to βG
conditioning (Figure 5a and
b), whereas βG-induced TNF secretion could not be observed by CD14CD16/M (Figure 5c and d). After a
resting period of two days, neither control nor βG-conditioned M0 or M1 CD14/M
secreted TNF in detectable amounts (Figure 6a and b). After the resting period,
no TNF was detectable in medium controls or βG-conditioned M0 or M1 CD14CD16/Mph
(Figure 6h and i).
Figure 5.
TNF secretion after βG treatment. Monocytes were selected as PA/M (a, b) or
CD14CD16/M (c, d) and treated with 10 µg βG on day 1 for 24 h. Supernatant
was collected and TNF contents measured by ELISA. Daily supplementation with
GM-CSF and IFN-γ occurred in b and d. Statistical significant differences
are indicated (*P < 0.05). PA/M: Monocytes isolated by
plastic adherence, CD14CD16/M: Monocytes expressing CD14 and / or CD16, βG:
β-glucan, GM-CSF: Granulocyte macrophage colony stimulating factor, IFN-γ:
Interferon γ, ELISA: Enzyme-linked immunosorbent assay, TNF: Tumor necrosis
factor.
Figure 6.
TNF secretion of bovine macrophages. Monocytes were selected as CD14/M (a,
b), single monocyte subsets (c, d, e), PA/M (f, g) or CD14CD16/M (h, i) from
six different animals and submitted to the protocol seen in Figure 1. Briefly,
cells were conditioned with 10 µg of βG and then stimulated with 10 ng of
LPS, with a 48 h-break in between. Daily supplementation with GM-CSF and IFN
γ occurred in b, c, d, e, g and i to polarize monocytes into M1 Mph. TNF
amounts were measured by ELISA in the supernatants at the end of the
experiment. Statistical differences are indicated
(*P < 0.05). PA/Mph: Plastic adherent macrophages
derived from PA/M, CD14/Mph: Macrophages derived from CD14/M, CD14CD16/Mph:
Macrophages derived from CD14CD16/M, cMph: Macrophages derived from
classical monocytes, intMph: Macrophages derived from intermediate
monocytes, ncMph: Macrophages derived from non classical monocytes, βG: β
glucan, LPS: Lipopolysaccharide, Mph: Macrophages, GM-CSF: Granulocyte
macrophage colony stimulating factor, IFN-γ: Interferon γ, ELISA:
Enzyme-linked immunosorbent assay, TNF: Tumor necrosis factor.
TNF secretion after βG treatment. Monocytes were selected as PA/M (a, b) or
CD14CD16/M (c, d) and treated with 10 µg βG on day 1 for 24 h. Supernatant
was collected and TNF contents measured by ELISA. Daily supplementation with
GM-CSF and IFN-γ occurred in b and d. Statistical significant differences
are indicated (*P < 0.05). PA/M: Monocytes isolated by
plastic adherence, CD14CD16/M: Monocytes expressing CD14 and / or CD16, βG:
β-glucan, GM-CSF: Granulocyte macrophage colony stimulating factor, IFN-γ:
Interferon γ, ELISA: Enzyme-linked immunosorbent assay, TNF: Tumor necrosis
factor.TNF secretion of bovine macrophages. Monocytes were selected as CD14/M (a,
b), single monocyte subsets (c, d, e), PA/M (f, g) or CD14CD16/M (h, i) from
six different animals and submitted to the protocol seen in Figure 1. Briefly,
cells were conditioned with 10 µg of βG and then stimulated with 10 ng of
LPS, with a 48 h-break in between. Daily supplementation with GM-CSF and IFN
γ occurred in b, c, d, e, g and i to polarize monocytes into M1 Mph. TNF
amounts were measured by ELISA in the supernatants at the end of the
experiment. Statistical differences are indicated
(*P < 0.05). PA/Mph: Plastic adherent macrophages
derived from PA/M, CD14/Mph: Macrophages derived from CD14/M, CD14CD16/Mph:
Macrophages derived from CD14CD16/M, cMph: Macrophages derived from
classical monocytes, intMph: Macrophages derived from intermediate
monocytes, ncMph: Macrophages derived from non classical monocytes, βG: β
glucan, LPS: Lipopolysaccharide, Mph: Macrophages, GM-CSF: Granulocyte
macrophage colony stimulating factor, IFN-γ: Interferon γ, ELISA:
Enzyme-linked immunosorbent assay, TNF: Tumor necrosis factor.
Purified bovine monocyte subsets and CD14+ monocytes cannot be trained by
ßG
Whereas M1 CD14/Mph secreted TNF after LPS stimulation (Figure 6B), neither M1 cMph, M1 intMph, nor
M1 ncMph secreted TNF after LPS stimulation (Figure 6c, d and e). βG-conditioned Mph
derived from CD14+ monocytes (CD14/MPh, Figure 6a) and Mph derived from purified cM,
intM, and ncM (cMph, intMph, ncMph, Figure 6c, d and e) displayed no enhanced
TNF secretion after LPS stimulation.
PA/M and CD14CD16/M can be trained by βG
βG-conditioned PA/Mph and M1 CD14CD16/Mph secreted significantly higher TNF amounts
after LPS stimulation. Although the training effect of βG could be observed in M0
PA/Mph (Figure 6f), the LPS
response was more pronounced with M1 Mph (Figure 6g and i; Table 1).
Table 1.
Trainability of different macrophage preparations.
Macrophage population
Seeded monocyte subpopulation
Macrophage polarization
Trainability
PA/Mph
cM, intM, ncM
M0
Yes
M1
Yes
CD14/Mph
cM, intM
M0
No
M1
No
cMph
cM
M1
No
intMph
intM
M1
No
ncMph
ncM
M1
No
CD14CD16/Mph
cM, intM, ncM
M0
No
M1
Yes
Trainability of different macrophage preparations.To evaluate the impact of the cellular composition of PA/M at the time of βG
conditioning for the memory effect (Me), we correlated Me with
fractions of CD2+ lymphoid cells (CD2+,
CD2+CD4+, CD2+CD8+), cM, intM, and
ncM among the PBMC before seeding. The fraction of ncM showed a high positive and
significant correlation with the training effect (R = 0.89,
p = 0.02) (Supplemental Table 1).
Discussion
The analysis of trained innate immunity with focus on primary macrophages requires
the separation of their precursors from blood[5,16-18] or bone marrow
followed by defined culture conditions. The protocols described for human
monocytes usually involve the purification of monocytes by plastic-adherence or by
magnetic-activated negative selection of monocytes.[17,18] Our initial protocol was
based on studies with human monocytes
and murine macrophages.
In accordance to
we incubated bovine cells with βG for 24 h and stimulated macrophages with
10 ng LPS for 24 h. This approach did not induce a consistent TNF release in M0 MPh,
however, trained immunity could be detected in bovine macrophages despite this
sub-optimal LPS concentration. Between conditioning/training with βG and LPS
stimulation we chose a resting period of 48 h, as a study in mice showed a training
effect with 24 h and 72 h resting periods.
For training, we used βG from Saccharomyces cerevisiae
preparation used for training in murine macrophages,
which was also shown to induce cytokine secretion by bovine monocytes.
The concentrations of βG were chosen according to concentrations used in
training experiments with human monocytes.[5,17,18] Whereas a trained phenotype
of human macrophages could be achieved with 1 µg βG derived from C.
albicans, bovine monocytes had to be trained with at least 5 µg βG from
Saccharomyces cerevisiae to achieve a more robust TNF release
after LPS stimulation (Supplemental Figure 1). This could be due to a species-specific
different sensitivity of monocytes towards βG or may reflect different affinities of
C. albicans and S. cervevisiae βG sources for
the receptor (Dectin-1) expressed on monocytes. A recent study underlined the
importance of the kind of βG, especially with regard to the potential to not only
bind but also to activate Dectin-1.The adaption of the commonly used strategy to train MACS-separated monocytes proved
to be insufficient to induce training in bovine CD14+ monocytes (Figure 6a and b). Whether
this was the consequence of an antibody-mediated pre-activation of cells after
positive MACS separation could not be resolved since, to the best of our knowledge,
negative selection of bovine monocytes is not possible at the moment. However, the
proof that positively selected whole bovine monocytes populations (CD14CD16M, see
below) can be trained, argues against a mere technical reason for the inability to
train bovine CD14+ monocytes with βG.Such positively selected bovine CD14+ monocytes contained both classical and
intermediate monocytes (Figure 2b), whereas negatively selected human monocytes were composed of
classical monocytes only.
Interestingly, classical human monocytes also could not be trained by βG
(C. albicans), which supports our finding that in vitro models
with single monocyte subsets may be insufficient to analyze innate immune training.
Other in vitro models took advantage of mixed monocytes populations. In the human
system these are, for instance monocyte preparations obtained after negative
selection of monocytes from PBMC after depletion of CD3-, CD19- and CD56-expressing
cells without characterizing the obtained monocyte subpopulations regarding their
CD14 and CD16 expression.
Using such monocyte preparations, putatively containing all monocytes
subpopulations, their trainability could be demonstrated.Indirectly, we could demonstrate the trainability of mixed/complete monocyte
subpopulations with macrophages generated from plastic-adherent monocytes (PA/M)
(Figure 6f and g). The
approach to use plastic adherent cells from PBMC preparations was used in several
human monocyte studies,[5,16] although the experimental details differed. We were not able to
prove that bovine cM, intM, and ncM adhered to the same extent to the plastic and
that differentiated Mph developed from all subsets. Moreover, this approach resulted
in an insufficient purity of Mph, with contaminating lymphoid cells still present on
day 5 (Figure 2c). Indirect
evidence, that these contaminating lymphocytes play no decisive role for the
βG-induced memory effect was the lack of correlation between memory effects and
individually different fractions of CD2+ lymphoid cells at the time of PBMC seeding
(Table S1). In contrast, however, the fraction of non-classical
monocytes among all monocytes in the PBMC fraction correlated strongly and
significant with the Me (Table S1). This could serve as a strong indication that the presence
and the amount of bovine ncM is crucial for the induction of trained in immunity in
bovine macrophages.To analyze this further and since we could not fully rule out a potential role of
contaminating lymphocytes among PA/Mph and their potentially secreted
training-regulating mediators, we established a MACS-based separation protocol for
all monocyte subpopulations by using CD14- and CD16-specific
para-magnetically-labeled antibodies simultaneously. The positively selected cell
populations were indeed composed of cM, intM, and ncM (Figure 2b), of which intM and ncM showed the
highest variation between individuals, and did not contain CD16+/CD335+ natural
killer cells (Figure S2). The trainability of this monocyte preparation
(CD14CD16/M) by βG further strengthened the hypothesis that non-classical monocytes
are necessary to achieve trained immunity in cattle. We hypothesize that different
monocyte subsets have to interact directly or indirectly with each other to achieve
training as we could not detect training when seeding single monocyte subsets.The different trained phenotypes of bovine Mph were not due to a differential
viability-modulating effect of βG conditioning (Figure 3) but depended on
monocyte-macrophage differentiation conditions: With the exception of M0 PA/MPh
(Figure 6f) we only
noted a trained or enhanced trained phenotype (Figure 6g) when monocytes were cultured in
the presence of M1-polarzing cytokines (Figure 6i).An enhanced MHC-II expression is one feature of M1 macrophages
and we noted this kind of enhanced expression on macrophages after addition
of M1-polarizing cytokines to PA/M, CD14/M, and CD14CD16M (Figure 4 ACD versus BDF). The expression
level of MHC-II molecules/cell differed between bovine Mph populations. Notably, M1
CD14CD16/Mph expressed only half of the amount compared to M1 PA/Mph or M1 CD14/Mph.
This may suggest that different bovine monocyte preparations respond differently to
GM-CSF and IFN-γ, probably regulated by mediators secreted from contaminating cells.
We tested the hypothesis, that there is endogenous production of IFN-γ by seeded
cells, but did not found consistent levels of IFN-γ 24 h after addition of cytokines
regardless of the seeded cell population (Table S2). However, the magnitude of MHC-II expression after bovine
macrophage differentiation in vitro does not seem to correlate with a functional
trained phenotype (compare Figure 4 and 5). We hypothesized, that the decrease in MHC-II expression after LPS and βG
stimulation may have been mediated by IL-10. LPS and βG have been shown to induce
IL-10 in bovine monocytes,[12,22] and IL-10 was shown to counteract an IFN-γ-induced upregulation
of MHC-II on human macrophages.
In line with those results, we noticed enhanced levels of IL-10 in the
supernatants of βG-treated M1-macrophages of all kinds, whereas LPS did not lead to
a stronger secretion of IL-10 in our settings (Figure S3).Overall, we found evidence for a contribution of non-classical monocytes in the
context of bovine monocyte/macrophage trained immunity. The task for the future is a
deeper characterization of crucial interactions with other monocyte subsets, the
identification of the actual cellular subset secreting higher TNF amounts after
secondary stimulation of complex macrophage populations, and the unraveling of
underlying mechanistic events.Click here for additional data file.Supplemental material, sj-docx-1-ini-10.1177_17534259221114219 for Non-classical
monocytes contribute to innate immune training in cattle by Lisa-Marie
Schünemann and Hans-Joachim Schuberth in Innate Immunity
Authors: Johanneke Kleinnijenhuis; Jessica Quintin; Frank Preijers; Leo A B Joosten; Daniela C Ifrim; Sadia Saeed; Cor Jacobs; Joke van Loenhout; Dirk de Jong; Hendrik G Stunnenberg; Ramnik J Xavier; Jos W M van der Meer; Reinout van Crevel; Mihai G Netea Journal: Proc Natl Acad Sci U S A Date: 2012-09-17 Impact factor: 11.205
Authors: Sadia Saeed; Jessica Quintin; Hindrik H D Kerstens; Nagesha A Rao; Ali Aghajanirefah; Filomena Matarese; Shih-Chin Cheng; Jacqueline Ratter; Kim Berentsen; Martijn A van der Ent; Nilofar Sharifi; Eva M Janssen-Megens; Menno Ter Huurne; Amit Mandoli; Tom van Schaik; Aylwin Ng; Frances Burden; Kate Downes; Mattia Frontini; Vinod Kumar; Evangelos J Giamarellos-Bourboulis; Willem H Ouwehand; Jos W M van der Meer; Leo A B Joosten; Cisca Wijmenga; Joost H A Martens; Ramnik J Xavier; Colin Logie; Mihai G Netea; Hendrik G Stunnenberg Journal: Science Date: 2014-09-26 Impact factor: 47.728
Authors: Yolanda Corripio-Miyar; Jayne Hope; Colin J McInnes; Sean R Wattegedera; Kirsty Jensen; Yvonne Pang; Gary Entrican; Elizabeth J Glass Journal: Vet Res Date: 2015-09-25 Impact factor: 3.683
Authors: Julia Leonhardt; Silke Große; Christian Marx; Fatina Siwczak; Sven Stengel; Tony Bruns; Reinhard Bauer; Michael Kiehntopf; David L Williams; Zhao-Qi Wang; Alexander S Mosig; Sebastian Weis; Michael Bauer; Regine Heller Journal: Front Immunol Date: 2018-11-30 Impact factor: 7.561
Authors: Ana R V Pedro; Tânia Lima; Ricardo Fróis-Martins; Bárbara Leal; Isabel C Ramos; Elisabete G Martins; Ana R J Cabrita; António J M Fonseca; Margarida R G Maia; Manuel Vilanova; Alexandra Correia Journal: Front Immunol Date: 2021-05-28 Impact factor: 7.561